Back to CAI
JPMORGAN CHASE & CO CAI Position History
Caris Life Sciences, Inc.
Quarters held
22
Latest value
$95K
Q2 2026
Peak value
$110.8M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $22M |
| Q3 2025 | $587K |
| Q3 2025 | $3.3M |
| Q3 2025 | $9K |
| Q4 2025 | $60.9M |
| Q4 2025 | $1.2M |
| Q4 2025 | $149K |
| Q4 2025 | $2.9M |
| Q4 2025 | $820K |
| Q1 2026 | $899K |
| Q1 2026 | $93K |
| Q1 2026 | $55M |
| Q1 2026 | $7K |
| Q1 2026 | $1.9M |
| Q1 2026 | $214K |
| Q1 2026 | $219K |
| Q2 2026 | $47K |
| Q2 2026 | $1.9M |
| Q2 2026 | $110.8M |
| Q2 2026 | $2.9M |
| Q2 2026 | $4.5M |
| Q2 2026 | $95K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $95K | 5.2K | — | — |
| Q2 2026 | $4.5M | 246.3K | — | — |
| Q2 2026 | $2.9M | 157.8K | — | — |
| Q2 2026 | $110.8M | 6.04M | — | — |
| Q2 2026 | $1.9M | 106.1K | — | — |
| Q2 2026 | $47K | 2.5K | — | — |
| Q1 2026 | $219K | 13.0K | — | — |
| Q1 2026 | $214K | 12.7K | — | — |
| Q1 2026 | $1.9M | 113.8K | — | — |
| Q1 2026 | $7K | 427 | — | — |
| Q1 2026 | $55M | 3.26M | — | — |
| Q1 2026 | $93K | 5.5K | — | — |
| Q1 2026 | $899K | 53.4K | — | — |
| Q4 2025 | $820K | 30.4K | — | — |
| Q4 2025 | $2.9M | 109.3K | — | — |
| Q4 2025 | $149K | 5.5K | — | — |
| Q4 2025 | $1.2M | 43.0K | — | — |
| Q4 2025 | $60.9M | 2.26M | — | — |
| Q3 2025 | $9K | 294 | — | — |
| Q3 2025 | $3.3M | 109.8K | — | — |
| Q3 2025 | $587K | 19.4K | — | — |
| Q3 2025 | $22M | 728.6K | — | — |
Other funds holding CAI
$166.7M
$142.8M
$122.2M
$109.1M
$109.1M
$109.1M
$102.5M